On August 27, 2018, Knowledge Ecology International (KEI) and the Union for Affordable Cancer Treatment (UACT) filed comments to the NIH regarding the prospective grant of two separate exclusive licenses to Sinotau Pharmaceutical Group and Molecular Targeting Technologies, Inc. (MTTI),… Continue Reading
The full document is here: govfunding-designs National (or regional) obligations to disclose funding in applications for IP protection, including designs Responses from Gemini.Google.Com when asked about national laws in several countries The World Intellectual Property Organization (WIPO) is holding a… Continue Reading
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading
Knowledge Ecology International (KEI) has sent a letter to Katherine Vidal, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) concerning an issue in Article 3 of the the World Intellectual Property… Continue Reading
On Monday afternoon, 9 September 2024, Knowledge Ecology International (KEI) delivered this statement on the legal architecture of the proposal for the WHO Pandemic Agreement. KEI has an open mind regarding the appropriate nature of the instrument or instruments for… Continue Reading
On September 3, 2024, Knowledge Ecology International (KEI) submitted comments to the NIH regarding the “Prospective Grant of an Exclusive Patent License: Dimethyl Synaptamide for the Treatment of Autoimmune Disorders and Inflammatory Diseases” (89 FR 66730). The Federal Register notice… Continue Reading
In advance of the September 2024 WHO pandemic negotiations (INB 11), Knowledge Ecology International (KEI), Innovarte, and Medicines Law & Policy (ML&P) will convene a virtual panel entitled, “Reflections on the IP & Technology Transfer provisions of the WHO Pandemic… Continue Reading
The National Institutes of Health (NIH) Office of Science Policy (OSP) posted a Request for Information (RFI) on the Draft NIH Intramural Research Program Policy: Promoting Equity Through Access Planning. The draft policy seeks, “to promote access to products stemming… Continue Reading
Knowledge Ecology International (KEI) offered the following comments to the National Institutes of Health (NIH) concerning the “Prospective Grant of an Exclusive Patent License: Antibody-Drug Conjugates (ADCs) for Targeting CD56-Positive Tumors” (89 FR 40495) to McSAF Inside Oncology SAS (McSAF).… Continue Reading
On Tuesday June 4, 2024, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding “Prospective Grant of an Exclusive Patent License: T Cell Receptor Fusion Proteins for the Treatment of Cancer” (89 FR 43859) to… Continue Reading